farnesol has been researched along with Burkholderia pseudomallei Infection in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bandeira, TJ; Brilhante, RS; Castelo-Branco, DS; Cordeiro, RA; Guedes, GM; Monteiro, AJ; Riello, GB; Rocha, MF; Serpa, R; Sidrim, JJ; Vasconcelos, DC | 1 |
1 other study(ies) available for farnesol and Burkholderia pseudomallei Infection
| Article | Year |
|---|---|
Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis.
Topics: Amoxicillin; Anti-Bacterial Agents; Biofilms; Burkholderia pseudomallei; Ceftazidime; Farnesol; Humans; Melioidosis; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |